The report analyzes the global near-infrared imaging market with respect to product type, application, end user, and region. The global near-infrared imaging market is projected to reach USD 471.2 million by 2020, at a CAGR of 8.8% from 2015 to 2020.
Based on product type, the global near-infrared imaging market is segmented into near-infrared fluorescence imaging, near infrared fluorescence & bioluminescence imaging devices, and reagents. The reagents segment accounted for the largest share of the global near-infrared imaging market in 2014. Factors responsible for the growth of reagents segment are increasing number of research institutions and industry funding towards research and development, rising applications of functional imaging, growing adoption rate for clinical imaging, and technological advancements.
North America accounted for the largest share of the global near-infrared imaging market in 2014. The near-infrared imaging market in North America region is driven by various factors such as technological advancements and increasing cancer cases. Europe is the fastest-growing regional market for near-infrared imaging due to increased technological advancements in the healthcare sector and development of new products.
The global near-infrared imaging market has been divided into four major regions, namely, Asia-Pacific, Europe, North America, and Rest of the World (RoW). These four regions are further segmented into major countries. North America accounted for the largest share of the near-infrared imaging market in 2014. The U.S. accounted for the largest share of the North America near-infrared imaging market in 2014. The U.S. near-infrared imaging market is growing due to the increasing cancer cases and favorable reimbursement scenario. Europe is the second-largest near-infrared imaging market. Germany is the leading country in the European near-infrared imaging market.
The major players profiled in the global near-infrared imaging market report include Biospace Lab (France), Fluoptics (France), Mizuho Corporation (Japan), Li-Cor, Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss Meditec AG (Germany), Novadaq Technologies Inc. (Canada), Hamamatsu Photonics K.K. (Japan), Karl Storz GmbH & Co. KG (Germany), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), and Miltenyi Biotech (Germany).
